These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38268787)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
    Sarraju A; Bakris G; Cannon CP; Cherney D; Damaraju CV; Figtree GA; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Neal B; Jardine MJ; Blais J; Kosiborod M; Levin A; Lingvay I; Weir MR; Perkovic V; Mahaffey KW
    J Am Coll Cardiol; 2022 Nov; 80(18):1721-1731. PubMed ID: 36302584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review.
    Norris KC; Smoyer KE; Rolland C; Van der Vaart J; Grubb EB
    BMC Nephrol; 2018 Feb; 19(1):36. PubMed ID: 29426298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
    Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
    J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
    Weldegiorgis M; de Zeeuw D; Li L; Parving HH; Hou FF; Remuzzi G; Greene T; Heerspink HJL
    Am J Kidney Dis; 2018 Jan; 71(1):91-101. PubMed ID: 29153995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.
    Liu JJ; Liu S; Wong MD; Gurung RL; Lim SC
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3794-3802. PubMed ID: 27459536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal function deterioration in adult patients with type-2 diabetes.
    Bramlage P; Lanzinger S; Hess E; Fahrner S; Heyer CHJ; Friebe M; Buschmann I; Danne T; Holl RW; Seufert J
    BMC Nephrol; 2020 Jul; 21(1):312. PubMed ID: 32727401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
    Hemmingsen B; Gimenez-Perez G; Mauricio D; Roqué I Figuls M; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003054. PubMed ID: 29205264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis.
    Harrison TG; Shukalek CB; Hemmelgarn BR; Zarnke KB; Ronksley PE; Iragorri N; Graham MM; James MT
    Am J Kidney Dis; 2020 Aug; 76(2):233-247. PubMed ID: 32387090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.
    Fernandez-Fernandez B; Sarafidis P; Kanbay M; Navarro-González JF; Soler MJ; Górriz JL; Ortiz A
    Clin Kidney J; 2020 Oct; 13(5):728-733. PubMed ID: 33123352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.
    Oshima M; Toyama T; Hara A; Shimizu M; Kitajima S; Iwata Y; Sakai N; Furuichi K; Haneda M; Babazono T; Yokoyama H; Iseki K; Araki SI; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Makino H; Wada T
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34193460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Jiang G; Luk AOY; Tam CHT; Xie F; Carstensen B; Lau ESH; Lim CKP; Lee HM; Ng ACW; Ng MCY; Ozaki R; Kong APS; Chow CC; Yang X; Lan HY; Tsui SKW; Fan X; Szeto CC; So WY; Chan JCN; Ma RCW;
    Kidney Int; 2019 Jan; 95(1):178-187. PubMed ID: 30415941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Autologous Cell Therapy in Type 2 Diabetes with Late Stage 4 Diabetes-Related Chronic Kidney Disease: Trial Design and Early Analysis.
    Stavas J; Thajudeen B; Coca S; Silva A; Butler E; Detwiler R; Burgner A
    Blood Purif; 2023; 52(2):114-121. PubMed ID: 36599315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.